Has Adam Allen received payments from drug or device companies?

Yes. Drug and device makers reported $4,846 in general payments to Adam Allen across 301 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Adam Allen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Adam Allen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Adam Allen

Psychiatric/Mental Health · Slidell, LANPI 1740549799

Payments from drug & device makers

$4,846in general payments, 2019–2025

Across 301 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Supernus Pharmaceuticals, Inc.$719
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$377
Axsome Therapeutics, Inc.$372
Johnson & Johnson$292
Corium, LLC$256
plus $2K from 16 others

What the payments were for

Food & beverage$4,833100%
Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	90	$1,260
Supernus Pharmaceuticals, Inc.	39	$719
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	32	$377
Axsome Therapeutics, Inc.	17	$372
Johnson & Johnson	6	$292
Corium, LLC	22	$256
Alkermes, Inc.	15	$247
Lundbeck LLC	18	$246
Ironshore Pharmaceuticals Inc.	15	$233
Otsuka America Pharmaceutical, Inc.	8	$214
Vanda Pharmaceuticals Inc.	6	$96
Takeda Pharmaceuticals U.S.A., Inc.	5	$78
Sunovion Pharmaceuticals Inc.	6	$77
Noven Therapeutics, LLC	4	$73
Tris Pharma Inc	4	$70
Collegium Pharmaceutical, Inc.	4	$70
Idorsia Pharmaceuticals US Inc	3	$53
Vertical Pharmaceuticals, LLC	2	$32
Almatica Pharma LLC	2	$30
Astellas Pharma US Inc	1	$26
Bausch Health US, LLC	1	$15
Eisai Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$236
Auvelity$121

How this compares

$4,846 in reported general payments places this provider in the 80th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	18	$626
Quetiapine Fumarate	24	$414
Buspirone Hcl	17	$258
Mirtazapine	15	$180
Aripiprazole	14	$159
Clonazepam	13	$158

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Slidell

Amy LacoutureBaton Rouge$663K
Amanda EymardHouma$617K
Amber LittlefieldBroussard$225K
Timothy PellegrinHouma$210K
Melissa GuilbeauLafayette$122K
Kimberly ForcinelShreveport$92K
Sattaria DilksLake Charles$57K
Joe TaylorHammond$38K
Lecy AlbaradoScott$34K
Michelle DyerLake Charles$33K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →